-
Article
Health-related quality of life analyses in nonfunctioning pituitary macroadenoma patients identifies at-risk populations
The quality of life (QoL) impact of multidisciplinary treatment for patients with nonfunctioning pituitary macroadenomas (NFPMA) is unclear. We sought to investigate associations between patient factors, clini...
-
Article
Open AccessSingle cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy
Immunotherapy fails to cure most cancer patients. Preclinical studies indicate that radiotherapy synergizes with immunotherapy, promoting radiation-induced antitumor immunity. Most preclinical immunotherapy st...
-
Chapter
Radiation and Immunotherapy for Sarcoma
Almost half of all cancer patients receive radiation therapy [1]. Radiotherapy is used for localized cancers to achieve local control and for metastatic tumors to palliate symptoms, and is estimated to contrib...
